Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Systemic pharmacokinetics refers to the quantitative study of how a drug substance is absorbed, distributed, metabolized, and excreted (ADME) by the body over time (StatPearls: Pharmacokinetics, 2023). It is not a biological target such as a receptor, enzyme, or transporter, but rather a pharmacological concept describing the movement of a drug through the systemic circulation and tissues (Merck Manual: Overview of Pharmacokinetics, 2022). Key parameters like clearance, volume of distribution, and half-life are utilized to determine optimal dosing regimens and predict drug behavior across diverse patient populations (FDA: Clinical Pharmacology Section of Labeling, 2016). Understanding systemic pharmacokinetics is essential for ensuring that a drug reaches its intended molecular target at a concentration that is both effective and safe. Factors such as age, genetics (pharmacogenomics), and underlying disease states can significantly alter these processes, necessitating dose adjustments to avoid toxicity or therapeutic failure.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Systemic pharmacokinetics (PK).